Trial NCT00672204

View at ClinicalTrials.gov 
Org. Study IDs: 0612M98726

Last trial update was posted on 2017-10-25

MeSH Interventions

Antilymphocyte Serum Sirolimus Thymoglobulin

MeSH Conditions

Diabetes Mellitus Diabetes Mellitus, Type 1 Hypoglycemia

Other Conditions

Type 1 Diabetes Mellitus

Stopping Reasons

Raptiva was withdrawn from the market

Limitations And Caveats

Early termination due to Raptiva being withdrawn from market

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID